AI & Technical question
Abridge has access to de-identified conversations, clinician edits, final signed notes, EHR context, and downstream care actions, but each signal differs in coverage, cost, bias, and clinical relevance. How would you prioritize which signals to use first for post-training, and what framework would you use to decide whether a sparse, subjective, or expensive signal is still worth operationalizing?
- Abridge
- AI & Technical
- Hard
Practice this question out loud. An AI interviewer asks it, follows up like a real interviewer would, and scores your answer. Type or speak.
Start a mock interview on this question · Mock interview from a job description
What this question tests
Tests prioritizing among multiple training signals that differ in coverage, cost, bias, and clinical relevance, and framing when a sparse or expensive signal is still worth using.
How to approach it
- Map each signal, de-identified conversations, clinician edits, final signed notes, EHR context, and downstream care actions, against coverage, since a signal only a few clinicians generate has limited near-term training value.
- Assess bias per signal: clinician edits reflect real quality feedback but may be biased toward clinicians who bother to edit at all, skewing which cases get corrected.
- Assess clinical relevance and cost: downstream care actions are the most clinically meaningful signal but likely the sparsest and most expensive to link back to a specific note.
- Prioritize high-coverage, lower-cost signals first, like final signed notes compared against generated drafts, since they're available at scale and directly measure output quality.
- Treat clinician edits as a high-value secondary signal despite bias, since edit patterns reveal specific failure types, but weight or correct for which clinicians tend to edit.
- Reserve sparse or expensive signals like downstream care actions for targeted validation of the highest-stakes failure modes, where their extra clinical relevance justifies the cost, rather than for broad training.
What a strong answer includes
- Explicitly separates coverage, cost, bias, and clinical relevance as independent axes instead of one combined usefulness score.
- Flags the specific bias risk in clinician-edit data, that only some clinicians edit, and proposes correcting for it rather than ignoring it.
- Sequences signal use by cost and coverage first, reserving the most expensive signal for targeted validation of the highest-stakes cases.
- Gives a concrete framework, is the added clinical relevance worth the sparsity and cost, for when a hard signal is still worth operationalizing.
Common mistakes
- Treating all signals as equally trustworthy without accounting for which clinicians actually generate edit data.
- Chasing the most clinically ideal signal, downstream care actions, first despite its sparsity and cost, delaying near-term progress.
- Ignoring cost and coverage entirely and optimizing purely for theoretical signal quality.
Likely follow-up questions
- How would you correct for clinician-edit bias in practice?
- What evidence would justify investing in the downstream care-action signal despite its cost?
More ai & technical questions
- Abridge has a post-training approach that uses clinician edits, final notes, and EHR context to improve note generation. How would you define the hypotheses, stage gates, and success metrics to take it from offline research to shadow mode to a limited production launch? What evidence would be required at each step to continue, pause, or kill the effort?Abridge · AI & Technical · Hard
- For a model that turns patient-clinician conversations into structured clinical notes, what evaluation suite would you use beyond aggregate quality scores? Specify the failure modes you would prioritize, how you would segment risk by workflow or note type, and the thresholds or escalation paths you would require before declaring the model safe enough to scale.Abridge · AI & Technical · Hard
- A chart-aware CDS assistant must feel fast enough for live clinical use while staying reliable and evidence-grounded. How would you work with engineering and ML to define the system tradeoffs and product requirements around latency, retrieval quality, grounding, fallback behavior, and failure handling, and what technical or model-level changes would you prioritize first if response time improved only by reducing answer quality?Abridge · AI & Technical · Hard
- Abridge has a new AI-assisted clinician workflow whose model quality is improving but still imperfect. What launch criteria would you set before exposing it in live care, how would you combine offline evals, human review, and UX guardrails, and how would you phase the rollout to manage clinical and compliance risk?Abridge · AI & Technical · Hard
- Production monitoring shows a model improves average note quality but increases rare critical errors. How would you investigate whether this is a measurement artifact, a distribution shift, or a real safety regression, and how would you decide between shipping, pausing, rolling back, or narrowing scope?Abridge · AI & Technical · Hard
- Abridge explicitly uses LLM judges, rule-based evaluators, human annotation, and online monitoring. How would you decide which of these methods belongs at each stage of the eval lifecycle, and what failure modes, cost/speed tradeoffs, and confidence limits would you communicate before teams rely on them for launch decisions?Abridge · AI & Technical · Hard
More questions from Abridge
Learn the skill behind it
Chapters of the AI PM course that teach what this question tests.
- Chapter 1: Foundations: the model and the decisions it forces on you
- Chapter 8: Evals: define good and make the number defensible
- Chapter 6: Agents and agentic architecture